Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Environmental Resilience and Transformation in times of COVID-19: Climate Change Effects on Environmental Functionality ; : 127-134, 2021.
Article in English | Scopus | ID: covidwho-1783091


A comparative assessment of dissolved oxygen (DO) and biochemical oxygen demand (BOD) of river Ganga during prelockdown and lockdown periods was made through analysis of data generated from real-time water quality motoring systems. The concentration data for DO and BOD are examined for (i) prelockdown period (March 15-21, 2020) and (ii) lockdown period (March 22-April 15, 2020). The analysis results show 3%-20% decrease in DO concentration. The slight decrease in DO observed at all locations during the first week after lockdown which may be due to the increased levels of suspended solids and turbidity in the river water because of heavy rains. DO during fourth week of lockdown has shown a decreased value as compared to the prelockdown period at most of the locations. However, in West Bengal the DO has increased in lockdown. BOD value ranged between 1.13 mg/L and 5.56 mg/L during lockdown period, more or less similar to prelockdown range of 1.37-5.58 mg/L. This chapter further discusses the cause of water quality changes during the period of lockdown as compare to prelockdown period. © 2021 Elsevier Inc.

Annals of Allergy, Asthma and Immunology ; 127(5):S43, 2021.
Article in English | EMBASE | ID: covidwho-1748293


Introduction: A single tertiary care center has offered oral immunotherapy (OIT) as a clinical service since 2018 using commercial products and subsequently has offered FDA-approved Peanut (Arachis- hypogaea) Allergen Powder-dnfp (PNAP) since July 2020. Shared decision making regarding OIT was based on previous IgE testing, history, and family preference. Methods: A retrospective chart review was performed in REDCap database. Results: A total of 37 patients initiated OIT (21 commercial products and 16 PNAP). The mean age was 9.25 for commercial product and 7.25 for PNAP with more males than females participating. Co-morbid conditions included allergic rhinitis, asthma, and eczema. Mean peanut IgE prior to starting was 49.75 and Ara h2 was 32.73. Prior reactions to peanut included skin, GI and anaphylaxis. Three children failed an oral challenge prior to starting OIT. There were 5 children that had never ingested peanuts but completed OIT. Minor intermittent side effects including stomach upset and itchy mouth were reported during escalation of both products. Dose adjustment was required for 1 PNAP patient for complaint of dysphagia and pain. There were 4 patients who dropped out of OIT: refusal to eat (1), unrelated GI disease (1) and the COVID-19 pandemic (2). All patients upon reaching maintenance are daily dosing with peanuts or chocolate-covered peanut candy. Lifestyle changes reported since reaching maintenance include eating in restaurants previously avoided and ingesting foods with labels stating: “may contain peanuts,” and “foods processed in a facility with peanuts.” Conclusions: Peanut OIT is safe and well tolerated in our patient population.

Indian Heart J ; 72(3): 145-150, 2020.
Article in English | MEDLINE | ID: covidwho-378208


An echocardiographic investigation is one of the key modalities of diagnosis in cardiology. There has been a rising presence of cardiological comorbidities in patients positive for COVID-19. Hence, it is becoming extremely essential to look into the correct safety precautions, healthcare professionals must take while conducting an echo investigation. The decision matrix formulated for conducting an echocardiographic evaluation is based on presence or absence of cardiological comorbidity vis-à-vis positive, suspected or negative for COVID-19. The safety measures have been constructed keeping in mind the current safety precautions by WHO, CDC and MoHFW, India.

Cardiovascular Diseases/diagnostic imaging , Coronavirus Infections/prevention & control , Cross Infection/prevention & control , Echocardiography/methods , Pandemics/prevention & control , Patient Safety , Pneumonia, Viral/prevention & control , COVID-19 , Cardiology , Cardiovascular Diseases/epidemiology , Coronavirus Infections/epidemiology , Female , Humans , India , Infection Control/methods , Male , Pandemics/statistics & numerical data , Pneumonia, Viral/epidemiology , Practice Guidelines as Topic , Severe Acute Respiratory Syndrome/epidemiology , Severe Acute Respiratory Syndrome/prevention & control , Societies, Medical